Karim, 2019 - Google Patents

Estrogen Receptor Beta Ligands Exert Pro-Myelinating Effects by Altering Pro-Inflammatory Responses in an Animal Model of Multiple Sclerosis

Karim, 2019

View PDF
Document ID
5872921743575335882
Author
Karim H
Publication year

External Links

Snippet

Multiple Sclerosis (MS) is a chronic inflammatory demyelinating and neurodegenerative disease with no known etiology nor cure. Current immunomodulatory drugs reduce inflammation or prevent leukocyte egress from lymph nodes, but neither halt disease …
Continue reading at escholarship.org (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders

Similar Documents

Publication Publication Date Title
RU2690670C2 (en) Reduced levels or activity of systemic regulatory t cells for treating disease or cns injury
Aharoni Immunomodulation neuroprotection and remyelination–The fundamental therapeutic effects of glatiramer acetate: A critical review
Gilgun-Sherki et al. Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis
AU2014340210A1 (en) Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
Meyer Zu Horste et al. Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies
US20170184612A1 (en) Use of leukocytes and novel biomarkers in the diagnosis, confirmation, and treatment of a neurological disorder
Laouarem et al. Functional cooperation of the hedgehog and androgen signaling pathways during developmental and repairing myelination
JP2006512396A (en) Methods for inducing and maintaining immune tolerance
Perera et al. Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injury
WO2019152516A1 (en) Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators
CN112512554A (en) Immunodominant proteins and fragments in multiple sclerosis
CN106030302B (en) treatment of neurodegenerative diseases
Dong et al. Pro-inflammatory cytokines and leukocyte integrins associated with chronic neuropathic pain in traumatic and inflammatory neuropathies: Initial observations and hypotheses
Dwyer et al. B cell treatment promotes a neuroprotective microenvironment after traumatic brain injury through reciprocal immunomodulation with infiltrating peripheral myeloid cells
Karim Estrogen Receptor Beta Ligands Exert Pro-Myelinating Effects by Altering Pro-Inflammatory Responses in an Animal Model of Multiple Sclerosis
JP2020522499A (en) Treatment of neuroinflammatory diseases
JP2020530846A (en) Method
CN115697391A (en) Improved vaccine formulations
van Noort et al. The pathogenesis of multiple sclerosis: a series of unfortunate events
Harry Microglia: neuroprotective and neurodestructive properties
Shang et al. B-cell targeted therapies in autoimmune encephalitis: mechanisms, clinical applications, and therapeutic potential
Khaw Assessment of the impact of early life trauma, changes in estrogen signaling, and neurotoxic molecules in a mouse model of multiple sclerosis
Eissa et al. Interrelation Between the Immune and the Nervous Systems in the Context of Cerebellar Development and Developmental Disorders
Lozinski Interactions of neurofibrosis and oligodendrogenesis following demyelination: Modulation by aging and exercise
Pouzol Preclinical development of ACT-1004-1239, a potent and selective CXCR7/ACKR3 antagonist in multiple sclerosis treatment